Â鶹ÊÓƵ

Companies can no longer look to simply litigate their way out of trouble in the ESG era – there are wider issues at stake

Judges Scientific has bought good companies at great prices and kept them growing. This is an excellent business with a price tag to match but one that may still reward patient long-term investors.

The 2010s were the decade of the smartphone. Which tech will dominate the 2020s?

Famed value investor Jeremy Grantham says we have entered a fully fledged epic bubble

After coronavirus, will the winners still take it all?

There are many reasons why the UK needs more creative equity financing

Genus' scarcity value means its shares are expensive, but long-term investors could still do well from owning them

What Professor Scott Galloway thinks will – and won’t – change in a world post Covid-19

Antitrust strictures need a rethink in the digital age regulators need a scalpel, not a broad sword

Free cash flow is widely used by investors – however, it is easy to make mistakes with it. While profits are sometimes treated with suspicion they can be better numbers to weigh up companies